Article
Genetic Characterization of Brain Metastases in the Era of Targeted Therapy
25 Sept 2017
Abstract excerpt
In the current era of molecularly targeted therapies and precision medicine, choice of cancer treatment has been increasingly tailored according to the molecular or genomic characterization of the cancer the individual has. Previously, the clinical observation of inadequate control of brain metastases was widely attributed to a lack of central nervous system (CNS) penetration of the anticancer drugs. However,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
